Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Unrevealed In clinical practice, acute form of ischemic heart disease: frequency, Laws, impact on Epidemiology

View through CrossRef
To analyse the frequency of unrecognized and/or unregistered fatal and nonfatal cases of acute coronary heart disease (CHD) and to estimate the unrecognized / unregistered cases influence on the acute CHD morbidity and mortality rate. Materials and methods. The unrecognized in medical documents acute CHD cases were actively revealed among 285 736 population according to the Study Design. Results. The portion of unrecognized cases in qualified acute CHD morbidity rate was 20.78% among males and 24.48% - among females, and 89.43% unrecognized cases had fatal outcome. In the issue of unrecognized cases revealing the acute CHD morbidity rate was increased by 26.24% among males and by 32.41% - among females, and the acute CHD mortality rate was increased in 2.13 and 2.28 times accordingly. Conclusion. The study results indicated the low acute CHD detectability in clinical practice and underestimate of acute CHD as cause of death.
Title: Unrevealed In clinical practice, acute form of ischemic heart disease: frequency, Laws, impact on Epidemiology
Description:
To analyse the frequency of unrecognized and/or unregistered fatal and nonfatal cases of acute coronary heart disease (CHD) and to estimate the unrecognized / unregistered cases influence on the acute CHD morbidity and mortality rate.
Materials and methods.
The unrecognized in medical documents acute CHD cases were actively revealed among 285 736 population according to the Study Design.
Results.
The portion of unrecognized cases in qualified acute CHD morbidity rate was 20.
78% among males and 24.
48% - among females, and 89.
43% unrecognized cases had fatal outcome.
In the issue of unrecognized cases revealing the acute CHD morbidity rate was increased by 26.
24% among males and by 32.
41% - among females, and the acute CHD mortality rate was increased in 2.
13 and 2.
28 times accordingly.
Conclusion.
The study results indicated the low acute CHD detectability in clinical practice and underestimate of acute CHD as cause of death.

Related Results

COVID impact on pattern of ischemic heart disease in comparable period
COVID impact on pattern of ischemic heart disease in comparable period
Aim: To compare the impact of COVID-19 on pattern of Ischemic Heart Disease in comparable period by assessing the incidence, severity of symptoms and in-hospital mortality of Ische...
Prevalence of Diabetes Mellitus in Acute Ischemic Stroke Patients at Tertiary Care Hospital
Prevalence of Diabetes Mellitus in Acute Ischemic Stroke Patients at Tertiary Care Hospital
Back ground: The third largest cause of death around the globe is stroke. In the United States the largest cause of disability is also stroke. For stroke and coronary heart diseas...
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
According to epidemiological studies, the leading cause of morbidity, disability and mortality are cerebrovascular diseases, in particular ischemic and hemorrhagic strokes. In rece...
GENETIC PERSPECTIVE OF THE CONGENITAL HEART DISEASE
GENETIC PERSPECTIVE OF THE CONGENITAL HEART DISEASE
Congenital heart diseases (CHDs) are the structural abnormalities that may occur in the heart, greater veins and arteries or may include the septum between the ventricles and atria...
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the fastest-growing cause of death around the world, and atherosclerosis plays a major role in the etiology of CVDs. The most recent figures show...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...

Back to Top